VTv Therapeutics: Fourth Quarter Earnings Overview
VTV Therapeutics Inc. Reports Fourth Quarter Financial Results
VTV Therapeutics Inc., headquartered in High Point, North Carolina, announced on Tuesday that it recorded a net loss of $7.1 million for the fourth quarter.
The company reported a quarterly loss of 58 cents per share.
These figures surpassed analysts’ expectations, as a consensus of three analysts polled by Zacks Investment Research had anticipated a loss of 98 cents per share.
For the entire fiscal year, VTV Therapeutics posted a total loss of $27 million, which equates to $3.20 per share.
Financial data for this article was compiled by Automated Insights using information from Zacks Investment Research.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
How Tron’s entry into AAIF could position TRX to lead AI agent boom

MRSH Crumbles 3.32% as $470M Volume Ranks 267th on March 10
GPT360 and MarsCat Global Announce Partnership to Strengthen Web3 Community Engagement
Fortinet Rises 0.47% with $490M in Trades, Ranking 254th as Earnings Outweigh Growth Worries
